Lapses in Oversight Compromise Omics Results

From The Embassy of Good Science
Revision as of 17:47, 25 October 2020 by Marc.VanHoof (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Cases

Lapses in Oversight Compromise Omics Results

What is this about?

Commentary on the Anil Potti case discussing relevant institutional changes in avoiding such misconduct. Potti was a researcher of cancer genomics at Duke University in Durham, North Carolina. His studies had linked changes in the expression of patients' genes with how they responded to cancer treatments, and independent statisticians had raised concerns about published papers linked to the work before clinical trials were initiated based on them. As the commentary highlights, there were a list of failures in the system of research oversight and integrity at the research institution, which must be corrected.

Why is this important?

It highlights the importance of institutional practices on research oversight and integrity that could serve as safeguards against research misconduct and other ethics failures.

For whom is this important?

Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6